Autek China Inc Total Liabilities

Latest as of March 2026: CN¥872.83 Million CNY ≈ $127.72 Million USD

Autek China Inc total liabilities. Based on the latest financial reports, Autek China Inc (300595) has total liabilities worth CN¥872.83 Million CNY (≈ $127.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Autek China Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Autek China Inc (2012–2025)

Total liabilities of Autek China Inc from 2012 to 2025. This chart illustrates how Autek China Inc's total liabilities have evolved over time, based on quarterly financial data.

Autek China Inc Competitors by Total Liabilities

The table below lists competitors of Autek China Inc ranked by their total liabilities.

Company Country Total Liabilities
Golden Ocean Group Limited
F:KT31
Germany €1.57 Billion
Schrodinger Inc
NASDAQ:SDGR
USA $311.44 Million
Advantage Oil & Gas Ltd.
TO:AAV
Canada CA$1.35 Billion
Shenzhen Aisidi Co Ltd
SHE:002416
China CN¥6.69 Billion
Kernel Holding SA
F:0KE
Germany €1.19 Billion
Zhongmin Energy Co Ltd
SHG:600163
China CN¥4.65 Billion
CLEARWAY ENERGY A NDL-01
F:NY4B
Germany €11.36 Billion
GH Research PLC
NASDAQ:GHRS
USA $12.86 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Autek China Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300595 total assets.

Liquidity & Leverage Metrics

Autek China Inc Total Liabilities Ratios Explained

Autek China Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 5.84 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Autek China Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Autek China Inc (2012–2025)

The table below shows the annual total liabilities of Autek China Inc from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥849.48 Million
≈ $124.31 Million
-4.26%
2024-12-31 CN¥887.24 Million
≈ $129.83 Million
+9.83%
2023-12-31 CN¥807.85 Million
≈ $118.21 Million
+54.45%
2022-12-31 CN¥523.05 Million
≈ $76.54 Million
+19.87%
2021-12-31 CN¥436.35 Million
≈ $63.85 Million
+96.79%
2020-12-31 CN¥221.74 Million
≈ $32.45 Million
+31.85%
2019-12-31 CN¥168.17 Million
≈ $24.61 Million
+15.76%
2018-12-31 CN¥145.28 Million
≈ $21.26 Million
+31.80%
2017-12-31 CN¥110.23 Million
≈ $16.13 Million
+165.23%
2016-12-31 CN¥41.56 Million
≈ $6.08 Million
-3.95%
2015-12-31 CN¥43.27 Million
≈ $6.33 Million
+138.95%
2014-12-31 CN¥18.11 Million
≈ $2.65 Million
+6.17%
2013-12-31 CN¥17.06 Million
≈ $2.50 Million
+56.76%
2012-12-31 CN¥10.88 Million
≈ $1.59 Million
--

About Autek China Inc

SHE:300595 China Medical Instruments & Supplies
Market Cap
$1.39 Billion
CN¥9.52 Billion CNY
Market Cap Rank
#7234 Global
#1471 in China
Share Price
CN¥10.63
Change (1 day)
+1.24%
52-Week Range
CN¥9.90 - CN¥17.20
All Time High
CN¥106.29
About

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It a… Read more